MycoFluor™ Mycoplasma Detection Kit
MycoFluor™ Mycoplasma Detection Kit
Invitrogen™

MycoFluor™ Mycoplasma Detection Kit

El kit de detección de micoplasma MycoFluor™ proporciona un ensayo microscópico de fluorescencia ultrasensible, rápido y simple para la identificaciónMás información
Have Questions?
Número de catálogoCantidad
M7006100 pruebas
Número de catálogo M7006
Precio (USD)
607,50
Each
Añadir al carro de la compra
Cantidad:
100 pruebas
Precio (USD)
607,50
Each
Añadir al carro de la compra
El kit de detección de micoplasma MycoFluor™ proporciona un ensayo microscópico de fluorescencia ultrasensible, rápido y simple para la identificación visual de la infección por micoplasma en cultivos celulares de laboratorio. Para detectar micoplasma, el reactivo fluorescente MycoFluor™ se añade directamente al medio de cultivo, con o sin células, y la muestra teñida se examina bajo un microscopio de fluorescencia.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Método de detecciónFluorescente
Para utilizar conMicroscopio de fluorescencia
Cantidad100 pruebas
Condiciones de envíoTemperatura ambiente
FormularioLíquido
Tipo de productoDetección de micoplasma
Unit SizeEach
Contenido y almacenamiento
Almacenar en el refrigerador (2–8 °C) y proteger de la luz.

Preguntas frecuentes

I suspect mycoplasma is affecting the growth rate of my culture. How can I test for it?

There are several options. Our first recommendation is to use the Invitrogen MycoFluor Mycoplasma Detection Kit.

Mycoplasmas are small, self-replicating prokaryotes (0.3 - 0.8 mm diameter), that lack a cell wall and have the ability to adsorb onto host cells. Mycoplasma is one of the most serious forms of cryptic contamination and its presence is not detected unless appropriate tests are made or until some aspect of cell behavior is noticed to have changed. Between 15 and 50% of cell lines submitted to cell banks are contaminated with mycoplasma. Mycoplasma spreads readily among cell lines via reagents and media, the operator and the work surface.

The presence of mycoplasma may invalidate the results obtained with that culture. The presence of mycoplasma-infected cultures can result in the shut-down of the entire laboratory until the infection can be eliminated, whereupon complete restocking is required. The origin of contamination is usually traced to mycoplasma present in animal (bovine) serum or to human oral mycoplasma transferred by droplet infection during cell culture. The simplest test for the detection of mycoplasma in cultures is the use of a fluorescent dye which binds directly to DNA causing fluorescence (e.g. Hoechst 33258) which can be seen by fluorescence microscopy. Mycoplasma positive cells will show intense fluorescent spots on the plasma membranes or show filaments which may be absorbed onto the cells. Uncontaminated cells show only brightly fluorescent cell nuclei. The technique is rapid (less than 30 minutes), but requires heavy contamination (10E6 mycoplasma/ml) to produce a clear positive result. If however, the suspect cells are co-incubated for 2-4 days with an "indicator" cell line (such as 3T3) which is particularly suitable for demonstration of positive staining, then sensitivity can be substantially increased. Microbiological culture techniques are available that operate at a greater sensitivity, but it can take up to 21 days to obtain a result, a positive control is needed, and the result may require expert interpretation.

A variety of PCR-based methods are available, some of which have been utilized as commercially available detection kits. It is recommended to use a combination of DNA staining and a PCR-based method once every 3 months for all growing cultures in the laboratory and for every new cell line as it enters the laboratory. In addition, all Master and Working Cell Banks should be tested at the time of freezing. Quality control and good working practice will reduce potential problems. It is important that frozen stocks are created immediately after testing and re-tested before distribution. If cells are cultured for more than 3 months after testing, they should be re-tested. Regulatory bodies now insist that cell cultures used for the production of reagents for diagnostic kits or therapeutic agents are free from mycoplasma infection. Also, some scientific journals have the policy of requiring statements from authors that the culture work reported in those journals is carried out with mycoplasma-free cells. Normally, when contamination with mycoplasma is apparent, the recommendation would be to discard the cultures and start again. If necessary, and only if the contamination is not extensive, then it is often possible to rescue the cells by treatment with one of the commercially available antibiotics. This must only be considered for a remedial action, not as a routine supplement to growth media (and thereby a substitute for good cell culture practice).

Which fluorescence filter should I use with the MycoFluor Mycoplasma Detection Kit (Cat. No. M7006)?

Samples prepared with the MycoFluor Detection Kit (Cat. No. M7006) can be visualized using a standard DAPI filter.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

Can I develop the MycoFluor MycoPlasma Detection Kit (Cat.No. M7006) into a 96-well format for screening with a plate reader?

We don't recommend doing this. Standard fluorescence microplates are not sensitive enough to detect the mycoplasma on the samples. The MycoFluor MycoPlasma Detection Kit is intended strictly for microscopic imaging.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

How can I remove mycoplasma contamination from my cell culture medium?

Very often mycoplasma contamination cannot be removed from the culture so it should be discarded. You may have a unique culture that you prefer not to discard and would like to try to clean it. Ciprofloxacin and Plasmocin have reportedly been used for this application. If interested in a protocol or directions for use, check with the antibiotic supplier or published literature. Note that mycoplasma are very difficult to remove from culture and spread easily so the treated cultures should be quarantined until clear of mycoplasma, and your laboratory should be thoroughly cleaned.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Citations & References (14)

Citations & References
Abstract
Characterization of a novel epigenetic effect of ionizing radiation: the death-inducing effect.
Authors:Nagar S, Smith LE, Morgan WF
Journal:Cancer Res
PubMed ID:12543783
'The detrimental effects associated with exposure to ionizing radiation have long been thought to result from the direct targeting of the nucleus leading to DNA damage; however, the emergence of concepts such as radiation-induced genomic instability and bystander effects have challenged this dogma. After cellular exposure to ionizing radiation, we ... More
Mechanisms of cell death associated with death-inducing factors from genomically unstable cell lines.
Authors:Nagar S, Smith LE, Morgan WF
Journal:Mutagenesis
PubMed ID:14614192
'We recently described a unique non-targeted effect of ionizing radiation whereby growth medium from two clones of GM10115 cells exhibiting radiation-induced chromosomal instability was cytotoxic to parental GM10115 cells. We termed this the death-inducing effect (DIE). The goal of the present study was to determine how DIE killed cells. Our ... More
Ionizing radiation induces delayed hyperrecombination in Mammalian cells.
Authors:Huang L, Grim S, Smith LE, Kim PM, Nickoloff JA, Goloubeva OG, Morgan WF
Journal:Mol Cell Biol
PubMed ID:15143196
Exposure to ionizing radiation can result in delayed effects that can be detected in the progeny of an irradiated cell multiple generations after the initial exposure. These effects are described under the rubric of radiation-induced genomic instability and encompass multiple genotoxic endpoints. We have developed a green fluorescence protein (GFP)-based ... More
Angiotensin subtype 1 rReceptor (AT1) blockade improves vasorelaxation in heart failure by up-regulation of endothelial nitric-oxide synthase via activation of the AT2 receptor.
Authors:Thai H, Wollmuth J, Goldman S, Gaballa M
Journal:J Pharmacol Exp Ther
PubMed ID:14560036
To determine whether angiotensin receptor blockade decreases vascular tone in heart failure by improving endothelial-dependent vasorelaxation and increasing nitric oxide (NO) bioavailability, we treated infarcted adult male Sprague-Dawley rats with candesartan for 7 days or 8 weeks (10 mg/kg/day in drinking water). Candesartan, at both time points, lowered left ventricular ... More
Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition.
Authors:
Journal:J Hematol Oncol
PubMed ID:32552902